Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Spratt

Showing results (411-420 of 498) with videos related to

Pageof 50
Sort By:
European Urology|May 23, 2017
Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy SpecimensPaul L Nguyen, Zaid Haddad, Ashley E Ross, et al.
Cancer Discovery|September 13, 2013
Androgen receptor signaling regulates DNA repair in prostate cancersWilliam R Polkinghorn, Joel S Parker, Man X Lee, et al.
The Journal of Urology|August 26, 2021
Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 ConsortiumPeter Chang, Andrew A Wagner, Meredith M Regan, et al.
The Lancet. Oncology|March 4, 2021
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysisLaila A Gharzai, Ralph Jiang, David Wallington, et al.
European Urology|December 14, 2017
Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence PostprostatectomyDaniel E Spratt, Darlene L Y Dai, Robert B Den, et al.
The Journal of Urology|August 29, 2018
International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone TherapyAlejandro Berlin, Fabio Y Moraes, Noelia Sanmamed, et al.
European Urology|June 26, 2025
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate DataSarah Burdett, David J Fisher, Jayne F Tierney, et al.
JCO Precision Oncology|September 11, 2020
Biologic Significance of Magnetic Resonance Imaging Invisibility in Localized Prostate CancerSimpa S Salami, Jeremy B Kaplan, Srinivas Nallandhighal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2020
Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized TrialsWilliam C Jackson, Holly E Hartman, Robert T Dess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2025
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III TrialsAndrew J Armstrong, Vinnie Y T Liu, Ramprasaath R Selvaraju, et al.
Pageof 50

Showing results (411-420 of 498) with videos related to

Sort By:
Pageof 50
European Urology|May 23, 2017
Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy SpecimensPaul L Nguyen, Zaid Haddad, Ashley E Ross, et al.
Cancer Discovery|September 13, 2013
Androgen receptor signaling regulates DNA repair in prostate cancersWilliam R Polkinghorn, Joel S Parker, Man X Lee, et al.
The Journal of Urology|August 26, 2021
Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 ConsortiumPeter Chang, Andrew A Wagner, Meredith M Regan, et al.
The Lancet. Oncology|March 4, 2021
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysisLaila A Gharzai, Ralph Jiang, David Wallington, et al.
European Urology|December 14, 2017
Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence PostprostatectomyDaniel E Spratt, Darlene L Y Dai, Robert B Den, et al.
The Journal of Urology|August 29, 2018
International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone TherapyAlejandro Berlin, Fabio Y Moraes, Noelia Sanmamed, et al.
European Urology|June 26, 2025
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate DataSarah Burdett, David J Fisher, Jayne F Tierney, et al.
JCO Precision Oncology|September 11, 2020
Biologic Significance of Magnetic Resonance Imaging Invisibility in Localized Prostate CancerSimpa S Salami, Jeremy B Kaplan, Srinivas Nallandhighal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2020
Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized TrialsWilliam C Jackson, Holly E Hartman, Robert T Dess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2025
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III TrialsAndrew J Armstrong, Vinnie Y T Liu, Ramprasaath R Selvaraju, et al.
Pageof 50